Validation of this synergic effect of statins and dexamethasone in other atherosclerosis models, such as the LDLR deficient mouse, may provide an indication regarding the need of precaution in the clinical administration of statins together with dexamethasone. The gene discussed is LDLR; the disease is atherosclerosis.